Insider · CIK 0001748622
Bhatt Elizabeth
Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA
Transactions
46
Companies
4
Filings
7
CIK
0001748622
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-11 | SEPNSepterna, Inc.M Exercise/Conversion | +$127K |
| 2026-08-11 | SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-08-11 | SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-08-11 | SEPNSepterna, Inc.S Sale | −$1.1M |
| 2026-08-11 | SEPNSepterna, Inc.M Exercise/Conversion | +$17.4K |
| 2026-07-15 | SEPNSepterna, Inc.S Sale | −$136K |
| 2026-07-15 | SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-07-15 | SEPNSepterna, Inc.M Exercise/Conversion | +$27.2K |
| 2026-04-15 | SEPNSepterna, Inc.S Sale | −$61.1K |
| 2026-04-15 | SEPNSepterna, Inc.S Sale | −$8,431.11 |
| 2026-04-15 | SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-04-15 | SEPNSepterna, Inc.S Sale | −$27.8K |
| 2026-04-15 | SEPNSepterna, Inc.M Exercise/Conversion | +$27.2K |
| 2026-02-18 | SEPNSepterna, Inc.S Sale | −$53.2K |
| 2026-02-18 | SEPNSepterna, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-02-18 | SEPNSepterna, Inc.S Sale | −$62.6K |
| 2026-02-18 | SEPNSepterna, Inc.M Exercise/Conversion | +$27.2K |
| 2026-02-06 | SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-08-07 | SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-13 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2024-02-19 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-06-22 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-01-20 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-06-09 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-02-15 | Applied Molecular Transport Inc.A Award | — |
| 2022-02-15 | Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award | — |
| 2021-12-24 | Applied Molecular Transport Inc.A Award | — |
| 2021-10-06 | eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.Class B Common StockD Disposition to Issuer | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.Class B Common StockC Conversion | — |
| 2021-08-25 | eFFECTOR Therapeutics, Inc.C Conversion | — |
| 2021-07-21 | Applied Molecular Transport Inc.S Sale | −$88.3K |
| 2021-07-21 | Applied Molecular Transport Inc.M Exercise/Conversion | +$41.5K |
| 2021-07-21 | Applied Molecular Transport Inc.S Sale | −$242K |
| 2021-07-21 | Applied Molecular Transport Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-04-21 | Applied Molecular Transport Inc.S Sale | −$219K |
| 2021-04-21 | Applied Molecular Transport Inc.S Sale | −$108K |
| 2021-04-21 | Applied Molecular Transport Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2021-04-21 | Applied Molecular Transport Inc.M Exercise/Conversion | +$41.5K |
| 2021-04-21 | Applied Molecular Transport Inc.S Sale | −$38.2K |
| 2021-03-01 | Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award | — |
| 2021-01-12 | eFFECTOR Therapeutics, Inc.Class B Common StockJ Other | — |
| 2019-02-21 | Achaogen, Inc.S Sale | −$864.19 |
| 2019-01-18 | Achaogen, Inc.A Award | — |
| 2018-10-31 | Achaogen, Inc.A Award | — |
| 2018-09-11 | Achaogen, Inc.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Bhatt Elizabeth0001193125-26-349810SEC(opens sec.gov)
- 4Bhatt Elizabeth0001193125-26-308073SEC(opens sec.gov)
- 4Bhatt Elizabeth0001193125-26-161987SEC(opens sec.gov)
- 4Bhatt Elizabeth0001193125-26-061675SEC(opens sec.gov)
- 4Bhatt Elizabeth0001193125-26-045097SEC(opens sec.gov)
- 4Bhatt Elizabeth0000950170-25-106798SEC(opens sec.gov)
- 4Bhatt Elizabeth0000950170-24-073195SEC(opens sec.gov)
Companies
Address
C/O SEPTERNA, INC. 250 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080